Company Filing History:
Years Active: 1999
Title: Terence A Potter: Innovator in Gene Therapy
Introduction
Terence A Potter is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of gene therapy, particularly in the regulation of effector cells. His work aims to provide therapeutic solutions for various diseases by manipulating the immune response.
Latest Patents
Terence A Potter holds a patent for a groundbreaking invention titled "Gene therapy for effector cell regulation." This patent presents a nucleic acid-based therapeutic composition designed to treat animals by controlling the activity of effector cells, including T cells, macrophages, monocytes, and natural killer cells. The therapeutic compositions include superantigen-encoding nucleic acid molecules, which can be combined with cytokine-encoding and chemokine-encoding nucleic acid molecules, depending on the specific disease being addressed. Additionally, the invention relates to an adjuvant for use with nucleic acid-based vaccines, which combines an immunogen with superantigen-encoding nucleic acid molecules.
Career Highlights
Terence A Potter is affiliated with the National Jewish Medical and Research Center, where he continues to advance his research in gene therapy. His innovative approach has the potential to revolutionize treatments for various diseases by enhancing the body's immune response.
Collaborations
Some of his notable coworkers include Steve W Dow and Robyn E Elmslie, who contribute to the collaborative efforts in research and development at the National Jewish Medical and Research Center.
Conclusion
Terence A Potter's work in gene therapy exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic strategies that could significantly impact the treatment of diseases.